Biodexa Pharmaceuticals Financial Statements 2014-2024 | BDRX

Fifteen years of historical annual and quarterly income statements for Biodexa Pharmaceuticals (BDRX).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM2023202220212020201920182017201620152014
$0.00$0.41$0.86$0.79$0.44$0.86$2.59$9.79$9.38$2.10$0.26
$0.00$0$0$0$0$0$0$1.19$0.90$0.11$0
$0.00$0.41$0.86$0.79$0.44$0.86$2.59$8.60$8.48$2.00$0.26
$0.00$4.40$6.32$6.40$7.79$10.01$12.49$13.13$9.06$9.05$8.96
$0.00$4.70$5.62$4.05$6.37$5.32$5.87$16.19$25.41$12.70$7.69
$0.00$0.02$0.03$0.03$-15.87$0.02$0$-1.93$-15.47$0$0
$0.00$0$0$0$0$0$0$31.25$49.93$21.75$0
$0.00$-8.67$-11.05$-9.62$-29.58$-14.45$-15.77$-22.65$-41.45$-19.75$-16.39
$0.00$0.57$0.55$1.23$-0.55$0.50$-0.78$0.32$1.71$2.58$-0.25
$0.00$-8.10$-10.50$-8.40$-30.14$-13.95$-16.55$-22.33$-39.74$-17.17$-16.64
$0.00$-0.44$-1.03$-0.89$-1.64$-2.28$-2.71$-1.63$-12.41$-1.73$-1.68
$0.00$-7.66$-9.47$-7.51$-28.49$-11.67$-13.84$-20.70$-27.33$-15.44$-14.97
$0.00$0$0$0$0$0$0$0$0$0$0
$0.00$-7.66$-9.47$-7.51$-28.49$-11.67$-13.84$-20.70$-27.33$-15.44$-14.97
$0.00$0$0$0$0$-1.21$-6.22$0$0$0$0
$0.00$-7.66$-9.47$-7.51$-28.49$-12.88$-20.06$-20.70$-27.33$-15.44$-14.97
$0.00$-8.37$-10.62$-9.07$-28.02$-12.81$-13.84$-19.36$-35.55$-18.62$-15.86
$0.00$-8.67$-11.05$-9.62$-29.58$-14.45$-15.77$-22.65$-41.45$-19.75$-16.39
$0.00$-216.46$-19,172.00$-19,252.00$-133,536.00$-140,500.00$-6.56$-0.80$-1.52$-1.10$-3.33
$0.00$-216.46$-19,172.00$-19,252.00$-133,536.00$-140,500.00$-6.56$-0.80$-1.52$-1.10$-3.33

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-06-302023-12-312023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312019-06-302018-12-312018-06-302017-12-312017-06-302016-12-312016-06-302015-12-312015-06-302014-12-31
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00